[
  {
    "ts": null,
    "headline": "Cencora Inc. stock outperforms competitors on strong trading day",
    "summary": "Cencora Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=66cf605a6573360415ac7ec987142163b35a553aa812cf30395286cfab1ac4da",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751906820,
      "headline": "Cencora Inc. stock outperforms competitors on strong trading day",
      "id": 135819318,
      "image": "",
      "related": "COR",
      "source": "MarketWatch",
      "summary": "Cencora Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=66cf605a6573360415ac7ec987142163b35a553aa812cf30395286cfab1ac4da"
    }
  },
  {
    "ts": null,
    "headline": "Stereotaxis Reports Positive Initial Data From MAGiC Catheter Trial",
    "summary": "STXS posts first peer-reviewed results for its MAGiC catheter, showing 94% efficacy and strong safety in arrhythmia treatment.",
    "url": "https://finnhub.io/api/news?id=dd8c740cdce3914a907ee98ff25e09e46cc55ce0506913233b83165fc8e61f36",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751903460,
      "headline": "Stereotaxis Reports Positive Initial Data From MAGiC Catheter Trial",
      "id": 135805204,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "STXS posts first peer-reviewed results for its MAGiC catheter, showing 94% efficacy and strong safety in arrhythmia treatment.",
      "url": "https://finnhub.io/api/news?id=dd8c740cdce3914a907ee98ff25e09e46cc55ce0506913233b83165fc8e61f36"
    }
  },
  {
    "ts": null,
    "headline": "Should You Retain Henry Schein Stock in Your Portfolio Right Now?",
    "summary": "Investors are optimistic about HSIC, owing to the strong Henry Schein One performance. However, macro headwinds and fierce competition pose challenges.",
    "url": "https://finnhub.io/api/news?id=572f163c6d3954821c5479e5a771df68375e7317c32f8a9de9bce9ca82030b25",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751890620,
      "headline": "Should You Retain Henry Schein Stock in Your Portfolio Right Now?",
      "id": 135786041,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "Investors are optimistic about HSIC, owing to the strong Henry Schein One performance. However, macro headwinds and fierce competition pose challenges.",
      "url": "https://finnhub.io/api/news?id=572f163c6d3954821c5479e5a771df68375e7317c32f8a9de9bce9ca82030b25"
    }
  },
  {
    "ts": null,
    "headline": "Quest Diagnostics Stock Climbs 27.3% in a Year: What's Fueling It?",
    "summary": "DGX stock surges 27.3% in a year, fueled by Advanced Diagnostics, key acquisitions and expanding health plan ties.",
    "url": "https://finnhub.io/api/news?id=5296d2670cb0403fe44be1998d75b5fdee31b42bc44d48ff03cd052393c86fe4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751889600,
      "headline": "Quest Diagnostics Stock Climbs 27.3% in a Year: What's Fueling It?",
      "id": 135786893,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COR",
      "source": "Yahoo",
      "summary": "DGX stock surges 27.3% in a year, fueled by Advanced Diagnostics, key acquisitions and expanding health plan ties.",
      "url": "https://finnhub.io/api/news?id=5296d2670cb0403fe44be1998d75b5fdee31b42bc44d48ff03cd052393c86fe4"
    }
  }
]